Monday, February 6, 2012

OphthaliX Announces the Appointment of Prof. Roger Kornberg as a Director

CARSON CITY, Nev., Feb. 6, 2012 /PRNewswire/ -- OphthaliX Inc. (OTCBB: OPLI) is pleased to announce the appointment of Professor Roger D. Kornberg to the Company's Board of Directors. Roger Kornberg is Winzer Professor in Medicine in the Department of Structural Biology at Stanford University. He moved to his present position in 1978, where his research has focused on the mechanism and regulation of eukaryotic gene transcription. In 2006, Professor Kornberg was awarded the Nobel Prize in Chemi...continued
 

No comments:

Post a Comment